(Image via YouTube)
A Johns Hopkins spinout has FDA approval and a Series A in hand, and is set to step up sales of its system to improve biopsy imaging.
Clear Guide Medical closed on $1.5 million in new funding, and could double that number with add-on investments in the near future. The round was led by Georgia-based Wildermuth Advisory.
Clear Guide Medical received its CE Mark on the SCENERGY today! A good way to end the week. We also had a… https://t.co/dDBhghPdQ7
— CLEAR GUIDE MEDICAL (@ClearGuide) April 15, 2016
The new money follows FDA approval in February for the company’s imaging product, called SCENERGY. Sold as an accessory to ultrasound machines, it includes a “SuperPROBE” that links an ultrasound’s existing probe with the Clear Guide system. It helps specialists conducting biopsies to work with CT and ultrasound images at the same time. The system also has an automated registration process designed to reduce time.
Formed by a group of Johns Hopkins researchers in 2010, Clear Guide Medical currently works with several hospitals. The startup is looking to expand sales in the U.S. and Europe.-30-
With more patients being treated at home, ICmed looks to help them stay connected to healthcare
Between Two Founders: Talking money education with Ortus Academy
Microsoft is throwing support behind these Hopkins AI and data science startups
Technology is ever evolving — shouldn’t business education be, too?
Protenus cofounder Robert Lord is returning to JHU medical school, joining LionBird Ventures as partner
Cashflow and confidence: Startup Portal opens space to work with entrepreneurs in Westminster
Chesapeake Digital Health Exchange aims to spur regional startup growth
How independence fuels confidence and professional development at SmartLogic
Sign-up for daily news updates from Technical.ly Baltimore